Eisai Co. Licenses Protein Expression Data Analysis System from Rosetta Biosoftware
News Jan 03, 2007
Eisai Co. will be using the Elucidator system in the Laboratory of Seeds Finding Technology to support LC-MS quantification methods for identifying potential neurology biomarkers.
“The Elucidator system will be an important tool for enabling quantitative methods and characterizing cancer proteomes by multidimensional LC-MS/MS,” said Yoshiya Oda, Ph.D., senior scientist at the Laboratory of Seeds Finding Technology.
“We are honored to provide the Elucidator system to this prestigious pharmaceutical company,” said Yelena Shevelenko, vice president and general manager of Rosetta Biosoftware.
“The Elucidator system supports end-to-end data management and analysis workflow for comparative proteomics, and provides multiple ways for scientists to analyze and refine their data to achieve high-confidence results.”
Scientists used a gene editing method called CRISPR/Cas9 to generate mice that faithfully mimic a fatal respiratory disorder in newborn infants that turns their lips and skin blue. The new laboratory model allowed researchers to pinpoint the ailment's cause and develop a potential and desperately needed nanoparticle-based treatment.READ MORE